In:
Prenatal Diagnosis, Wiley, Vol. 37, No. 12 ( 2017-12), p. 1238-1244
Abstract:
What is already known about this topic? cfDNA screening for trisomy 21 has higher sensitivity, lower false positive rate, and higher positive predictive value than standard screening. What does this study add? Cohort study of low risk women who received results of both standard and cfDNA screening with outcome of pregnancies collected in all cases. Direct demonstration of the reduction of invasive testing based on cfDNA screening. Demonstration of limited clinical utility of nuchal translucency measurement in women with a negative cfDNA test result.
Type of Medium:
Online Resource
ISSN:
0197-3851
,
1097-0223
Language:
English
Publisher:
Wiley
Publication Date:
2017
detail.hit.zdb_id:
1491217-X
Permalink